Organisme : Michael J. Fox Foundation for Parkinson's Research
	Projets financés à l'Université Laval
		Novel non-invasive gene therapy for Parkinson’s disease using viral encoded single-chain antibody treatment
		Targeting the blood-brain immune axis to prevent dissemination and progression of Parkinson’s disease